• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Pfizer to sell Schneider angio unit

Article

Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider

Pharmaceutical company Pfizer of New York City announced last month that it is exploring alternatives for its Medical Technology Group that could include the divestiture of the business as a whole or in parts. The division includes Pfizer's Schneider Worldwide business, which develops interventional radiology and cardiology products such as angioplasty balloon catheters. Other units in the business include Howmedica, which develops orthopedic devices, and American Medical Systems, a developer of urological implants. Pfizer was active in the medical imaging market in the 1980s, marketing such technologies as CT and mammography, but eventually exited the business.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.